Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer
Status:
Not yet recruiting
Trial end date:
2026-09-30
Target enrollment:
Participant gender:
Summary
A randomized, double-blinded, placebo-controlled clinical trial using a Chinese Medicine
'Coriolus Versicolor for improving the quality of life of patients with advanced-stage
cancer. Subjects will be randomized into a treatment group or placebo group for 6 months.